What does this research mean for the field?

AT1-receptor antagonism with losartan reverses blood pressure elevations caused by diet-induced obesity, demonstrating that the renin-angiotensin system plays a primary role in obesity-associated hypertension. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

March 18, 2005AJP Regulatory Integrative and Comparative Physiology

AT₁-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity

View Full Paper

Ask AI

Bookmark

Why the study?

Does losartan reduce blood pressure in obesity-prone rats fed a high-fat diet?

Structured PICO

Does losartan reduce blood pressure in obesity-prone rats fed a high-fat diet?

Population

Male Sprague-Dawley rats fed a moderately high-fat (MHF) diet (32% kcal as fat), segregated into obesity-prone (OP) and obesity-resistant (OR) groups.

Intervention

Losartan (AT1-receptor antagonist) administered at week 9.

Comparator

Obesity-resistant (OR) rats receiving the same diet and losartan treatment.

Outcome

24-h mean arterial blood pressure measured via telemetry.surrogate

Losartan effectively reverses blood pressure elevations in diet-induced obesity in rats, highlighting the role of the renin-angiotensin system in obesity-associated hypertension.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports differential RAS sensitivity in obesity models; extends preclinical data but leaves open human translation.

Cite This Study

Boustany et al. (2005) studied this question.

synapsesocial.com/papers/6a1dd7cad10dad54e1ef60ef https://doi.org/10.1152/ajpregu.00507.2004

View Full Paper

Ask AI

Bookmark